GelMEDIX
PrivateLast Round
Seed Round
Apr 30, 2026
Total Funding Raised
$34.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GelMEDIX is a biotechnology company developing regenerative therapies that restore vision by regenerating damaged retinal cells using a proprietary injectable hydrogel scaffold platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GelMEDIX Comparables
Compare GelMEDIX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoLize | 78% | |
| Paldara Pharmaceuticals | 78% | |
| Nexgel Biotech Co., Ltd. | 78% |
GelMEDIX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 30, 2026 | ||||
| Seed | Feb 17, 2026 | ||||
| VC Round | Jan 8, 2026 | ||||
| Seed | Oct 20, 2025 | ||||
| Debt | Mar 26, 2024 | ||||
Series A | Aug 9, 2022 |
Key People
Founding team and executive leadership
GelMEDIX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TiE Boston | Seed |
| Beacon Angels | Seed |
| Safar Partners | Series A, Seed |
| TiE Boston Angels | Seed |
| Boston Harbor Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
$747K raised in Seed Round.
- Feb 17, 2026
$13M round led by Safar Partners.
GelMEDIX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GelMEDIX's valuation, stock price, and market status.
Is GelMEDIX a public or private company?
GelMEDIX is a private company.
What is the current stock price of GelMEDIX?
GelMEDIX is a private company with no public stock price. No recent secondary market data is available.
How much is GelMEDIX worth (valuation)?
Valuation information for GelMEDIX is not publicly available.
Can I buy GelMEDIX stock?
GelMEDIX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GelMEDIX's last funding round?
GelMEDIX's most recent funding round was Seed Round on April 30, 2026.
Who are the main investors in GelMEDIX?
Key investors in GelMEDIX include Safar Partners.
Will GelMEDIX IPO soon?
No public IPO plans have been announced for GelMEDIX.
How can I track GelMEDIX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GelMEDIX's secondary market activity and sign up for updates.